Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1541063
PUBLISHER: IMARC | PRODUCT CODE: 1541063
Meningococcal Vaccines Market Report by Vaccine Type, Composition, Vaccine Serotype, Distribution Channel, End User, and Region 2024-2032
PUBLISHED:
PAGES: 137 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global meningococcal vaccines market size reached US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032.
Meningococcal vaccine refers to a biological substance administered for the prevention of meningitis, which is a contagious infection of the membranes surrounding the spinal cord and the brain. The three main kinds of meningococcal vaccines include conjugate, polysaccharide and subcapsular meningococcal vaccines. They are administered to infants, children and adults to immunize them against the invasive disease and target meningococcal bacteria A, B, C, W-135 and Y. Once the vaccine is administered, antibodies are formed to fight the bacteria and create an immune response to prevent the infection in the future.
The increasing prevalence of the meningococcal disease among young children and adolescents across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising health consciousness among the masses and the adoption of routine immunization are providing a thrust to the market growth. Meningococcal vaccine aids in preventing the disease and minimizing the long-term effects, such as temporary or permanent deafness, loss of vision and motor skills, seizure and neurological damage. In line with this, governments of both developed and emerging economies are launching extensive public health programs while emphasizing on the immunization of special risk groups, such as tourists and military personnel, to contain the risks of infections. Additionally, various product innovations, such as the development of ready-to-use liquid formulations that do not require reconstitution, are also contributing to the market growth. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global meningococcal vaccines market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on vaccine type, composition, vaccine serotype, distribution channel and end user.
Breakup by Vaccine Type:
Conjugate
Polysaccharide
Subcapsular
Breakup by Composition:
Mono Vaccines
Combination Vaccines
Breakup by Vaccine Serotype:
MenACWY
MenB & Manic
MenC
MenA
MenAC
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Institutional Sales
Others
Breakup by End User:
Pediatric
Adult
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.
Key Questions Answered in This Report:
- How has the global meningococcal vaccines market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global meningococcal vaccines market?
- What are the key regional markets?
- What is the breakup of the market based on the vaccine type?
- What is the breakup of the market based on the composition?
- What is the breakup of the market based on the vaccine serotype?
- What is the breakup of the market based on the distribution channel?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global meningococcal vaccines market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A2730
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Meningococcal Vaccines Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Vaccine Type
- 6.1 Conjugate
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Polysaccharide
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Subcapsular
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Composition
- 7.1 Mono Vaccines
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Combination Vaccines
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Vaccine Serotype
- 8.1 MenACWY
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 MenB & Manic
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 MenC
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 MenA
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 MenAC
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by Distribution Channel
- 9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Institutional Sales
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by End User
- 10.1 Pediatric
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Adult
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 GlaxoSmithKline Plc
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 Hualan Biological Engineering Inc.
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.3 Incepta Pharmaceuticals Limited
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.4 Novartis AG
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 Financials
- 16.3.4.4 SWOT Analysis
- 16.3.5 Pfizer Inc.
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 Sanofi S.A.
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 Financials
- 16.3.6.4 SWOT Analysis
- 16.3.7 Serum Institute of India Ltd.
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.8 Walvax Biotechnology Co. Ltd.
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.1 GlaxoSmithKline Plc
Product Code: SR112024A2730
List of Figures
- Figure 1: Global: Meningococcal Vaccines Market: Major Drivers and Challenges
- Figure 2: Global: Meningococcal Vaccines Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Meningococcal Vaccines Market: Breakup by Vaccine Type (in %), 2023
- Figure 4: Global: Meningococcal Vaccines Market: Breakup by Composition (in %), 2023
- Figure 5: Global: Meningococcal Vaccines Market: Breakup by Vaccine Serotype (in %), 2023
- Figure 6: Global: Meningococcal Vaccines Market: Breakup by Distribution Channel (in %), 2023
- Figure 7: Global: Meningococcal Vaccines Market: Breakup by End User (in %), 2023
- Figure 8: Global: Meningococcal Vaccines Market: Breakup by Region (in %), 2023
- Figure 9: Global: Meningococcal Vaccines Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 10: Global: Meningococcal Vaccines (Conjugate) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Meningococcal Vaccines (Conjugate) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Meningococcal Vaccines (Polysaccharide) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Meningococcal Vaccines (Polysaccharide) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Meningococcal Vaccines (Subcapsular) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Meningococcal Vaccines (Subcapsular) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Meningococcal Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Meningococcal Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Meningococcal Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Meningococcal Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Meningococcal Vaccines (MenACWY) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Meningococcal Vaccines (MenACWY) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Meningococcal Vaccines (MenB & Manic) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Meningococcal Vaccines (MenB & Manic) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Meningococcal Vaccines (MenC) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Meningococcal Vaccines (MenC) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Meningococcal Vaccines (MenA) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Meningococcal Vaccines (MenA) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Meningococcal Vaccines (MenAC) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Meningococcal Vaccines (MenAC) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Global: Meningococcal Vaccines (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Global: Meningococcal Vaccines (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Global: Meningococcal Vaccines (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Global: Meningococcal Vaccines (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Global: Meningococcal Vaccines (Institutional Sales) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Global: Meningococcal Vaccines (Institutional Sales) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Global: Meningococcal Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Global: Meningococcal Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Global: Meningococcal Vaccines (Pediatric) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Global: Meningococcal Vaccines (Pediatric) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Global: Meningococcal Vaccines (Adult) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Global: Meningococcal Vaccines (Adult) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: North America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: North America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: United States: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: United States: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Canada: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Canada: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Asia Pacific: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Asia Pacific: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: China: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: China: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Japan: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Japan: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: India: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: India: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: South Korea: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: South Korea: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Australia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Australia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Indonesia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Indonesia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Europe: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Europe: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Germany: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Germany: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: France: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: France: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: United Kingdom: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: United Kingdom: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Italy: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Italy: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Spain: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Spain: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Russia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Russia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 81: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 82: Latin America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 83: Latin America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 84: Brazil: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 85: Brazil: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 86: Mexico: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 87: Mexico: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 88: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 89: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 90: Middle East and Africa: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
- Figure 91: Middle East and Africa: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 92: Global: Meningococcal Vaccines Industry: SWOT Analysis
- Figure 93: Global: Meningococcal Vaccines Industry: Value Chain Analysis
- Figure 94: Global: Meningococcal Vaccines Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Meningococcal Vaccines Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2024-2032
- Table 3: Global: Meningococcal Vaccines Market Forecast: Breakup by Composition (in Million US$), 2024-2032
- Table 4: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Serotype (in Million US$), 2024-2032
- Table 5: Global: Meningococcal Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
- Table 6: Global: Meningococcal Vaccines Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 7: Global: Meningococcal Vaccines Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 8: Global: Meningococcal Vaccines Market: Competitive Structure
- Table 9: Global: Meningococcal Vaccines Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.